Chen Shaohua, Jin Ziyao, Xin Linfeng, Lv Lv, Zhang Xuemei, Gong Yizhen, Liu Jianlun
Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nangning, People's Republic of China.
Department of Breast and Thyroid Surgery, Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Int J Gen Med. 2021 Dec 14;14:9733-9745. doi: 10.2147/IJGM.S342597. eCollection 2021.
We aimed to investigate the expression, diagnostic and prognostic values, and potential molecular mechanisms of the origin recognition complex (ORC) in breast cancer (BC).
Kaplan-Meier estimation was used to assess the prognostic value of genes, and Oncomine, TCGA, GEO and ULCAN databases were used to analyze their expression in BC. Wilcoxon rank-sum tests were used to evaluate the relationship between gene expression levels and BC clinicopathological features. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of genes in BC. Survival analysis was performed using Kaplan-Meier estimation and Cox regression. A nomogram was constructed to predict 1-, 3-, and 5-year survival probabilities in BC. Gene set enrichment analysis (GSEA) and immune infiltration were used to investigate potential molecular mechanisms of the ORC.
and were highly expressed in BC compared with healthy tissue, while expression patterns were inconsistent; no significant differences in or expression were observed between BC and healthy tissues. and expression levels were significantly correlated with age, tumor (T) stage and molecular subtype; expression was significantly correlated with age and number of nearby lymph nodes with cancer (N stage). expression had the highest diagnostic value in BC and was an independent prognostic factor for poor overall survival (OS). ORC6L may be involved in cell cycle progression and may regulate cancer signaling pathways, including NF-κB, P53, and WNT, in BC. expression was also associated with immune infiltration.
and are highly expressed in BC; has a high diagnostic value and is an independent prognostic factor for poor OS. ORC6L may be involved in the initiation and progression of BC by regulating cell cycle progression, promoting cancer signaling pathway activation, and influencing tumor immune cell infiltration.
我们旨在研究起始识别复合物(ORC)在乳腺癌(BC)中的表达、诊断和预后价值以及潜在分子机制。
采用Kaplan-Meier估计法评估基因的预后价值,并利用Oncomine、TCGA、GEO和ULCAN数据库分析其在BC中的表达。采用Wilcoxon秩和检验评估基因表达水平与BC临床病理特征之间的关系。采用受试者工作特征(ROC)曲线评估基因在BC中的诊断价值。使用Kaplan-Meier估计法和Cox回归进行生存分析。构建列线图以预测BC患者1年、3年和5年的生存概率。采用基因集富集分析(GSEA)和免疫浸润分析来研究ORC的潜在分子机制。
与健康组织相比, 和 在BC中高表达,而 表达模式不一致;在BC和健康组织之间未观察到 或 表达的显著差异。 和 表达水平与年龄、肿瘤(T)分期和分子亚型显著相关; 表达与年龄和附近癌性淋巴结数量(N分期)显著相关。 在BC中具有最高的诊断价值,并且是总生存期(OS)较差的独立预后因素。ORC6L可能参与细胞周期进程,并可能调节BC中的癌症信号通路,包括NF-κB、P53和WNT。 表达也与免疫浸润相关。
和 在BC中高表达; 具有较高的诊断价值,并且是OS较差的独立预后因素。ORC6L可能通过调节细胞周期进程、促进癌症信号通路激活以及影响肿瘤免疫细胞浸润参与BC的发生和发展。